Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms in the Era of IDH Inhibitors
Authors
Leah Goldberg,
James YoonHannah Johnston,
Marta Davidson,
Alexa Siddon,
Rory Shallis,
Evan Chen,
Madelyn Burkart,
Timothy Oh,
Sunil Iyer,
Ellen Madarang,
Chandrasekar Muthiah,
Joshua Kassner,
Raajit Rampal,
Guru Murthy,
Terrence Bradley,
Yasmin Abaza,
Jacqueline Garcia,
Vikas Gupta,
Kristen Pettit,
Olatoyosi Odenike,
John Cursio +20 authors
,
Anand Patel Tip Tip